Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4088/PCC.21cr03220 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rash caused by lurasidone in old chinese patient with bipolar disorder: case-based review.
BMC Psychiatry
July 2024
Department of Pharmacy, Tongde Hospital of ZheJiang Province, Hangzhou, Zhejiang, People's Republic of China.
Background: Rash is one of common adverse drug reaction and which have been reported in typical and atypical antipsychotics. Reports of lurasidone induced skin reactions are sparse. In this study, we report a case of rash caused by lurasidone.
View Article and Find Full Text PDFFactors associated with increased risk of lurasidone-induced somnolence: Two case-control studies based on one bioequivalence trial in healthy volunteers.
Heliyon
July 2023
Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Wuhan, 430030, China.
Somnolence is a common adverse effect of antipsychotic drugs used to treat psychotic disorders. It causes problems in many areas of life, such as gainful employment, driving, childcare, and social interactions. Somnolence is a major problem for a relatively new antipsychotic drug, lurasidone, whose dose-effect relationship remains unclear.
View Article and Find Full Text PDFA Case of Lurasidone-Induced Urinary Retention.
Prim Care Companion CNS Disord
December 2022
Department of Psychiatry and Behavioral Neurosciences, Tampa General Hospital, University of South Florida, Tampa, Florida.
Lurasidone-induced hyperosmolar hyperglycemic syndrome: A case report.
Neuropsychopharmacol Rep
September 2022
Department of Psychiatry, Kyoto University Hospital, Kyoto, Japan.
Introduction: Lurasidone has few metabolic adverse effects and is recommended as an alternative when other antipsychotic drugs considerably increase body weight or blood sugar concentrations.
Case Presentation: An 81-year-old man with bipolar disorder developed hyperosmolar hyperglycemic syndrome as a side effect of lurasidone. Routine monitoring of blood glucose concentrations led to the early detection and treatment of this disease, preventing life-threatening complications.
Lurasidone-Induced Manic Switch in an Adolescent with Bipolar I Disorder: a Case Report.
East Asian Arch Psychiatry
September 2021
Department of Psychological Medicine, Changi General Hospital, Singapore.
Lurasidone is used for treatment of bipolar depression in adults and adolescents. Lurasidone-associated manic switch has been reported in adults but not yet in adolescents. We report a case of lurasidone-induced manic switch in a male adolescent treated for bipolar I depression.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!